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Abstract
Background: Differences in degree of environmental exposure to antigens in early life have been
hypothesized to lead to differences in immune status in individuals from different populations,
which may have implications for immune responses in later years.
Methods: Venous blood from HIV-negative adolescents and blood from the umbilical cords of
babies, born to HIV-negative women, post-delivery was collected and analysed using flow
cytometry. T cell phenotype was determined from peripheral blood lymphocytes and
cytomegalovirus (CMV) seropositivity was assessed by ELISA in adolescents.
Results: HIV-negative Malawian adolescents were shown to have a lower percentage of naïve T
cells (CD45RO-CD62Lhi CD11alo), a higher proportion of memory T cells and a higher percentage
of CD28- memory (CD28-CD45RO+) T cells compared to age-matched UK adolescents. Malawian
adolescents also had a lower percentage of central memory (CD45RA-CCR7+) T cells and a higher
percentage of stable memory (CD45RA+CCR7-) T cells than UK adolescents. All of the adolescents
tested in Malawi were seropositive for CMV (59/59), compared to 21/58 (36%) of UK adolescents.
CMV seropositivity in the UK was associated with a reduced percentage of naïve T cells and an
increased percentage of CD28- memory T cells in the periphery. No differences in the proportions
of naïve and memory T cell populations were observed in cord blood samples from the two sites.
Conclusion: It is likely that these differences between Malawian and UK adolescents reflect a
greater natural exposure to various infections, including CMV, in the African environment and may
imply differences in the ability of these populations to induce and maintain immunological memory
to vaccines and natural infections.
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Background
The immune system maintains both naïve and memory T
cells, so that individuals can mount an immune response
to a variety of new antigens while keeping appropriate lev-
els of memory T cells that recognise previously encoun-
tered pathogens. Naïve and memory T cells can most
simply be characterised by the reciprocal expression of the
CD45RA or CD45RO isoforms [1,2]. In general, naïve
(CD45RA+/CD45RO-) T cells represent the most homoge-
neous pool of T cells as they lack most effector functions.
These cells migrate through secondary lymphoid organs
seeking antigens presented by dendritic cells [3,4]. Once
they encounter antigen and become activated through the
T cell receptor, they proliferate and generate effector T
cells that are CD45RO+ with a variety of functions and
that can migrate into tissues [5]. A small proportion of
these effector cells persist as memory cells which give an
accelerated response upon a future encounter with the
specific antigen [6]. Such memory T cells can be subdi-
vided further by their expression of the chemokine recep-
tor CCR7 into central memory and effector memory T
cells with distinct functions and homing capabilities [7].
As individuals age and encounter more new antigens, the
proportion of naïve T cells declines and that of antigen-
experienced memory cells increases. In older individuals,
there is a generalised age-dependent decline in cell-medi-
ated immune responses. This includes reduction in the
numbers and proportions of naïve T cells, an accumula-
tion and clonal expansion of memory and effector T cells
and shrinkage of the T cell repertoire [8]. This is accompa-
nied by an expansion of memory T cells that lack expres-
sion of the costimulatory molecule CD28 and a decrease
in circulating CD28+ cells [9]. Among several factors
known to be associated with such changes is seropositivity
to persistent viral infections such as cytomegalovirus
(CMV) [10]. CMV infection is known to drive T cells
toward oligoclonality, end-stage differentiation and repli-
cative senescence [11,12], which, in elderly individuals,
may contribute to increased susceptibility to infectious,
neoplastic and degenerative diseases [13,14].
Comparative studies of lymphocyte phenotypes in
healthy HIV-negative individuals from Ethiopia and The
Netherlands [15,16], found that Ethiopians had fewer
naïve T cells, and more effector and memory T cells than
the Dutch. The authors concluded that the immune sys-
tem of the Ethiopians was more activated compared to
that of the Dutch, possibly reflecting the more frequent
exposure to various infections in the African environment.
We, and others, have shown that Mycobacterium bovis
bacille Calmette Guerin (BCG) vaccination, which is
highly effective against pulmonary tuberculosis (TB) in
adolescent recipients in the UK [17], provides little meas-
urable additional protection in adults in Malawi [18] and
in many other tropical countries [19]. We have also
shown differences in T cell cytokine responses to myco-
bacterial antigens between Malawi and the UK, both
before and after primary BCG vaccination, in young
adults and adolescents [20]. Differences between these
populations in the proportions of naive, memory and/or
more differentiated memory T cells, perhaps attributable
to the more frequent natural exposure to various infec-
tious agents in Africa, may be a factor contributing to the
difference in the ability of Malawians to respond to BCG
vaccination. This could influence their capability to
respond to other new antigens, either from infections or
vaccines.
Here, we compare the proportions of naïve, memory and
CD28- memory (CD28-CD45RO+) T cells in adolescent
and young adult HIV-negative Malawian and UK individ-
uals, using a panel of antibodies and four-colour flow
cytometry to determine the phenotype of T cells in periph-
eral blood. We also measured CMV seropositivity and
assessed the association between anti-CMV IgG antibod-
ies and T cell phenotype. The findings suggest that by ado-
lescence, the Malawians have an immune system that has
been challenged with more antigens including those from
infections that may impact on the induction and mainte-
nance of T cell memory.
Methods
Subjects
Subjects were recruited in rural northern Malawi and in
suburban south east UK, between August 2002 and Febru-
ary 2003 and December 2002 and April 2003 respectively,
in the context of a large comparative study of immune
responses to BCG vaccination [20].
In Malawi, we identified adolescents and young adults
with no history or evidence of BCG vaccination from
records of the Karonga Prevention Study (KPS) which has
been studying leprosy, tuberculosis and BCG vaccination
in Karonga District since 1979 [18]. These individuals
were recruited in their homes with informed, written con-
sent from the individual or guardian, including permis-
sion to perform an HIV test. Evidence of a BCG scar, signs
of TB, leprosy or other severe illness, generalised rashes,
pregnancy or HIV positivity resulted in exclusion from the
study. HIV serology was performed using both a particle
agglutination test (Edgware modification of Serodia, Mast
Diagnostics Ltd, Bootle, UK) and an ELISA (Vironostika
HIV Uni-form plus 0, Organon Teknika Ltd, Cambridge,
UK).
In the UK, we recruited adolescents through the schools'
BCG programme operated by the Redbridge and Waltham
Forest Primary Care Trusts in Essex, UK. Children born
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between 1988 and 1990 were invited by letter to partici-
pate in the study at the time of their routine BCG vaccina-
tion and were included after written consent from parent
or guardian and verbal consent from the child, had been
obtained. Exclusion criteria were evidence of previous
BCG vaccination (BCG scar or vaccination records) or
serious infections or immunomodulatory disease.
Fifty nine (36% male) healthy, HIV sero-negative adoles-
cents and young adults, aged 12–25 years, with no scar or
record of BCG vaccination were recruited in Malawi, and
an equal number with no BCG scar or record of vaccina-
tion in the UK (age range 12–14, 47% male). The first 33
and 30 individuals recruited in Malawi and UK respec-
tively were used to assess the proportion of naïve T cells
and CD28 expression and the remaining 26 and 29 in
Malawi and UK respectively, were used to examine CCR7
expression.
In both Malawi and UK, neonates were recruited during
prospective cohort studies on responses to BCG vaccina-
tion in infants. Neonatal (cord blood) samples were taken
following delivery of babies from HIV negative women
from whom written consent had been obtained at Chi-
lumba Rural Hospital, Karonga District, Malawi and at
Whipps Cross University Hospital, Leytonstone, UK.
Nineteen (47% male) and 13 (62% male) cord blood
samples were collected in Malawi and the UK respectively.
Ethical approval for these studies was obtained from the
National Health Sciences Research Committee in Malawi,
the Redbridge and Waltham Forest Health Authority Local
Research Ethics Committee, the Whipps Cross Hospital
Research Ethics Committee and the Ethics Committee of
the London School of Hygiene & Tropical Medicine in the
UK.
Cell preparation
Peripheral blood mononuclear cells (PBMC) were sepa-
rated from 10 ml of heparinised venous or umbilical cord
blood samples using Histopaque density gradient centrif-
ugation (Sigma-Aldrich, Poole, UK) and LeucoSep® tubes
(Greiner Bio-One, Frickenhausen, Germany) according to
the manufacturer's instructions. In the cord blood sam-
ples, red cells remaining after the Histopaque step were
lysed by osmotic shock.
Phenotyping of T cell subsets
Aliquots of 2 × 105 PBMC were stained with a panel of sur-
face molecule-specific antibodies to the following T cell
markers that were either directly conjugated to FITC, PE,
PerCP or APC or biotinylated, with streptavidin-APC used
as a secondary labelling reagent: CD3, CD4, CD8, CD11a,
CD28, CD45RA, CD62L, CD45RO and CCR7. All the
antibodies were obtained from BD Biosciences, UK. The
stained cells were fixed using either CellFix (BD Bio-
sciences, UK) in Malawi or 2% paraformaldehyde in the
UK and stored at 4°C. After gating on the small lym-
phocyte population, 10,000–30,000 events per tube were
acquired on a four-colour FACSCalibur flow cytometer
(BD Biosciences, UK). Analysis was performed using Cel-
lQuest™ software. Reagents obtained from the same
source and standardized protocols for cell staining, acqui-
sition and analyses, as well as exchange of personnel, were
used throughout to ensure comparability of results
between Malawi and the UK. There was no evidence of dif-
ferences in the percentages of small lymphocytes, CD4+
(p = 0.14) or CD8+ (p = 0.09) T cells in adolescents from
the two countries (results not shown).
Cytomegalovirus (CMV) antibody testing
Anti-CMV IgG serum antibody titres were determined for
the 59 Malawian and 58/59 UK adolescents using an
ELISA assay (ETI-CYTOK-G PLUS, DiaSorin, Italy) accord-
ing to the manufacturer's instructions. A result above 0.4
IU/ml was taken to indicate a current or past CMV infec-
tion.
Statistical analysis
Analysis was carried out using Stata™ 8.2 (Statacorp,
USA). Histograms were plotted to examine data distribu-
tions. T tests were used to compare groups if the data were
approximately normally distributed, the mean was within
3% (in absolute terms) of the median and the number of
individuals in each group was at least 10. When this was
not the case non-parametric tests (Wilcoxon Rank Sum
Test) were used.
The effect of age was examined among Malawian individ-
uals 12–25 years old and by comparing neonates to ado-
lescents aged 12–15, separately for Malawi and the UK. As
preliminary analyses found evidence of age-associated dif-
ferences in the percentages of CD3+, CD4+ and CD8+ T
cells among Malawian individuals, to allow valid compar-
isons between Malawi and the UK, we restricted our com-
parisons in the adolescent group to Malawians of a
comparable age to the UK adolescents (12–15 years old)
unless otherwise stated.
Results
Proportion of CD3+ T cells that are "truly naïve"
Although naïve CD4 and CD8 T cells express CD45RA,
long-term CD8 T memory cells can also re-express
CD45RA [21]. "Truly naïve" cells have high expression of
CD62L and low expression of LFA1 (assayed by staining
for CD11a) in addition to CD45RA [22]. We used these
markers to further define our naïve population as those
CD4+ or CD8+ T cells that were CD45RO-, CD62Lhi and
CD11alo. The mean percentage of CD4+ and CD8+ T cells
that were "truly naïve" was higher in the UK adolescents
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compared to the Malawians adolescents (p < 0.001 and p
= 0.019 respectively; Table 1)
Proportion of CD3+ CD45RA+ T cells that are CD28+
Loss of the costimulatory molecule CD28 expression in
both CD4+ and CD8+ T cells is an indication of antigen
experience [23,24]. Proportions of naïve T cells that are
CD28+ are greatest in neonates and decrease with age and
antigen experience [25,26].
There was no evidence of a difference between the
Malawian and UK neonates for the mean percentages of
CD28+ naïve CD4+ or CD8+ T cells in cord blood samples
(data not shown). Adolescents in Malawi and the UK had
lower mean percentages of CD4+ and CD8+ CD28+ naive T
cells compared to neonates (CD4+ CD28+ naïve T cells,
mean of 92% in Malawian cords versus 87% in UK cords;
CD8+ CD28+ naïve T cells, 76% compared to 79% in
Malawian and UK cords, respectively). Consistent with
our findings of a difference in naïve T cell proportions (as
measured by CD45RA, CD11a and CD62L expression) in
adolescents from the two countries, Malawian adolescents
had considerably lower percentages of both CD4+ and
CD8+ CD28+ naive T cells than UK adolescents (CD4+
CD28+ naïve T cells, mean of 61 (range 40–73)% in
Malawi versus 77 (range 63–88)% in the UK, p < 0.001;
CD8+ CD28+ naïve T cells, mean of 56 (range 36–82)% in
Malawi compared to 68 (range 28–91)% in the UK, p =
0.009)(Figure 1).
Proportion of CD3+ CD45RO+ and CD45RO- T cells that 
are CD28-
Consistent with the finding of fewer CD28+ naïve T cells,
we saw that Malawian adolescents had higher percentages
of CD4+ and CD8+ memory T cells that lacked CD28
expression (i.e. CD28-CD45RO+) than did UK adoles-
cents (CD4+ CD28-CD45RO+ T cells, mean of 1 (range 0–
4)% in Malawi versus 0.4 (range 0–3)% in the UK, p =
0.008; CD8+ CD28-CD45RO+ T cells, mean of 9 (range 1–
23)% in Malawi compared to 4 (range 0–12)% in the UK,
p < 0.001). Malawian adolescents also had higher percent-
ages of CD8+ revertant memory T cells that lacked CD28
expression (i.e. CD28-CD45RO-) though the evidence for
the latter difference was weak (p = 0.07, data not shown).
This was apparent particularly within the CD8+ T cell com-
partment and suggested that Malawian adolescents had
been exposed to more immune stimulation than UK indi-
viduals of a similar age.
CCR7 expression
Memory T cells can be categorised into central and effector
memory T cells based on the expression of the chemokine
receptor CCR7 [7]. Four T cell subsets have been
described: naïve cells (CD45RA+CCR7+), central memory
cells (CD45RA-CCR7+), effector memory cells (CD45RA-
CCR7-) and stable or revertant memory cells
(CD45RA+CCR7-). In keeping with our finding of a lower
mean percentage of T cells that were naïve in Malawians,
we found that, based on CCR7 expression, Malawian ado-
lescents had lower mean percentages of naïve CD4+ and
CD8+ T cells than UK adolescents; this was highly signifi-
cant for the CD8 population, although the difference in
naïve CD4+ CCR7+ T cells was of only borderline signifi-
cance for the 12–15 year old age group (p = 0.09) becom-
ing more significant in the older (16–25 year old) age
group (p = 0.003) (see Table 2). When we examined the
memory T cell phenotypes defined by CCR7 expression, it
was found that, for both CD4+ and CD8+ T cells, Malawian
adolescents had a lower percentage of central memory
and a higher percentage of stable memory T cells than UK
adolescents. There was no evidence of differences in the
percentages of effector memory cells between the two
populations.
CMV seropositivity and T cell phenotype
As infection with CMV is associated with functional and
phenotypic changes in T cells such as loss of CD28 expres-
sion and terminal differentiation, the proportion of
Malawians and UK adolescents who were CMV seroposi-
tive was assessed. One hundred percent (59/59) and 36%
(21/58) of Malawian and UK adolescents respectively
were positive for anti-CMV IgG antibodies. The associa-
tions between CMV seropositivity and T cell phenotype,
which could only be examined in the UK adolescents as
all the Malawians tested were CMV seropositive are pre-
sented in Table 3. CMV seropositivity was associated with
a decreased proportion of CD4+ T cells and an increased
proportion of CD8+ T cells (data not shown); this has pre-
viously been reported in elderly seropositive individuals
and is a feature of an "immune risk" phenotype associated
Table 1: Mean proportion of "truly naïve" T cells in Malawian and UK adolescents (aged 12–15 years).
Malawi (n = 19) UK (n = 26) p (difference)
% CD4+ "truly naïve" (min-max) 50 (27–70)
SD = 11.7
72 (55–87)
SD = 7.6
<0.001
% CD8+ "truly naïve" (min max) 47 (18–71)
SD = 12.9
56 (28–80)
SD = 12.7
0.019
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CD28 expression in CD4+ and CD8+ T cells from Malawian and UK adolescentsFigure 1
CD28 expression in CD4+ and CD8+ T cells from Malawian and UK adolescents. (a) Box and whisker plots showing 
proportions of CD28 expressing naive (CD28+CD45RO-) CD4+ and CD8+ T cells in Malawian (n = 19) and UK (n = 29) ado-
lescents. (b) Box and whisker plots showing proportions of CD28- memory (CD28-CD45RO+) CD4+ and CD8+ T cells in 
Malawian (n = 19) and UK (n = 29) adolescents. Each box shows the median and 25th and 75th centiles. The "whiskers" show 
the minimum and maximum values, other than "extreme" values that are detected as outliers and shown as circles above and 
below the "whiskers".
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with poor survival in old individuals [27]. CMV seroposi-
tive UK adolescents had fewer "truly naïve" CD4+ and
CD8+ T cells compared to negative individuals; this differ-
ence reached significance in the CD8+ population (p =
0.02). CMV infection was also associated with increased
percentages of both CD4+ and CD8+ CD28-CD45RO+ T
cells. CMV seropositive individuals had a lower percent-
age of both CD4+ and CD8+ central memory (CD45RA-
CCR7+) T cells compared to CMV seronegative adoles-
cents. This could be due to a loss of central memory cells
or their redistribution to lymphoid tissue but our data
suggest that it is likely to be due to an accumulation of
effector (CD45RA-CCR7-) and stable memory
(CD45RA+CCR7-) T cells, as the proportions of both pop-
ulations are raised in the CMV seropositive compared to
the CMV seronegative individuals (see Table 3).
Conclusion and discussion
In this study, we show that, at a similar age, Malawians
have a lower percentage of naïve T cells and a higher per-
centage of CD28- memory T cells than UK individuals. We
also show that all our Malawian study subjects are CMV
seropositive compared to only 36% of age-matched UK
adolescents.
In our study, which controls for age, differences in naïve
and memory T cells are shown between adolescents from
Malawi and the UK and almost certainly reflect immuno-
logical experience over the lifetime of the individuals. As
expected, a comparison of cord blood T cells from the two
populations showed little difference in the proportion of
naïve CD4+ T cells. Differences in proportions of naïve
and memory T cells are likely to develop early in life, as a
Table 2: Median percentages of naïve and memory T cells based on CCR7 expression in Malawian and UK adolescents (12–15 year 
olds) and young adults (16–25 year olds) stratified by age.
UK adolescents
(n = 30)
Malawi adolescents
whole group
(n = 26)
Malawi adolescents
(12-15 year olds)
(n = 5)
Malawi young adults
(16-25 year olds)
(n = 21)
CD4+ CD8+ CD4+ CD8+ CD4+ CD8+ CD4+ CD8+
%CCR7 naïve
(i.e. CD45RA+CCR7+)a
median 43 55 25 19 27 16 23 21
range 1–79 15–87 0.4–59 1–72 24–38 9–41 0.4–59 1–72
p 0.002 <0.001 0.09 0.001 0.003 0.001
%CCR7 memory that are central memory
(i.e. CD45RA-CCR7+)b
median 47 24 14 4 9 1 14 5
range 2–90 0–73 1–84 0.1–54 3–42 0.5–6 1–84 0.1–54
p 0.004 0.001 0.007 0.003 0.02 0.01
%CCR7 memory that are effector memory 
(i.e. CD45RA-CCR7-)c
median 29 29 41 31 36 27 42 32
range 4–50 0–56 15–76 12–56 15–41 14–34 15–76 12–56
p 0.02 0.81 0.48 0.48 0.01 0.57
%CCR7 memory that are stable memory 
(i.e. CD45RA+CCR7-)d
median 18 42 35 60 52 73 27 52
range 0.2–95 9–100 0.3–82 16–87 17–82 61–83 0.3–59 16–87
p 0.16 0.03 0.02 0.02 0.50 0.12
P values versus UK adolescents, based on Wilcoxon rank-sum test. Ranges are minimum and maximum values.
a Percentage of all CCR7 cells that are naïve.
b, c, d Of the CCR7 cells that are memory, proportion that are either central memory (b), effector memory (c) or stable memory (d) (percentages in 
b, c, and d sum to 100).
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comparative study of adults, children and neonates by
Tsegaye et al [28] showed a reduction in naïve (CD45RO-
CD27+) T cells before the age of 5 and suggested that this
was due to antigenic challenge from birth onwards.
Malawian adolescents have proportionately fewer naïve
CD4+ and CD8+ T cells than UK adolescents, whether
naïve T cells were characterised only by expression of
CD45RA (CD45RO- cells) or by combinations of markers
which are considered to identify "truly naïve" T cells
(CD45RO- with CD11a and CD62L or CD45RA with
CD28 or CCR7). This is the first study to show such a dif-
ference in proportions of naïve T cells in age-matched
adolescents from two countries although this has been
described for elderly (>60 year olds) compared to younger
individuals [24,29].
Consistent with the finding of proportionately fewer
naïve T cells, Malawian adolescents have proportionately
more memory (CD45RA-CD45RO+) T cells, and more dif-
ferentiated memory T cells (CD28-CD45RO+) than UK
adolescents. The reduction that we observe in the repre-
sentation of naïve T lymphocytes with a concomitant
increase in more differentiated memory T cells is similar
to findings in elderly individuals [30], although it may
have arisen by different mechanisms in the Malawian
adolescents. The effect of a reduction in naïve T cells in the
peripheral pool is the contraction of the T cell repertoire
leading to poor T cell responses to new antigens (see
review by Nikolich-Zugich [8]).
In a study of the effect of intestinal parasites on T cells
phenotypes in Ethiopian adults, Kassu et al [31] con-
cluded that persistent intestinal parasitic infections could
result in the up regulation of T cell activation markers on
CD4+ and CD8+ T cells, which the authors suggested
would result in an imbalanced immune status which may
lead to increased susceptibility to infections such as HIV.
The authors showed that treatment of these various intes-
tinal infections results in a reduction of the activated T cell
phenotypes; in HIV negative individuals they showed an
increase in naïve CD4+ T cells, a decrease in memory/effec-
tor cells and a decrease in cytotoxic effector CD8+ T cells.
It may be that intestinal pathogens have far reaching
effects on immune function susceptibility to disease and
on responses to vaccines(as reviewed in [32]) and that
their perturbation of immune responses may be reversi-
ble.
Table 3: Mean percentages of naïve and memory T cells in 12–15 year old CMV seronegative and seropositive UK adolescents.
CD4+ CD8+ p value
CMV
seronegative
CMV
seropositive
CMV
seronegative
CMV
seropositive
CD4+ CD8+
n = 19 n = 10 n = 19 n = 10
%CCR7 na&#239ve
(i.e. CD45RA+CCR7+)a
(range) 46 (2–79) 34 (1–57) 60 (43–87) 40 (15–58) 0.14 <0.001
%CCR7 memory that are central memory 
(i.e. CD45RA-CCR7+)b
(range) 54 (2–90) 41 (19–74) 32 (0–73) 14 (1–36) 0.16 0.021
%CCR7 memory that are effector memory
(i.e. CD45RA-CCR7-)c
(range) 26 (4–45) 35 (20–50) 27 (0–48) 33 (10–56) 0.06 0.27
%CCR7 memory that are stable memory
(i.e. CD45RA+CCR7-)d
(range) 21 (0–95) 24 (0–56) 41 (15–100) 52 (9–83) 0.72 0.21
n = 18 n = 9 n = 15 n = 11
% "truly naïve" (range) 75 (55–87) 69 (57–77) 63 (28–80) 51 (39–66) 0.06 0.02
n = 18 n = 11 n = 18 n = 11
% CD28- memory 
(CD28-CD45RO+) T cells
(range) 0.2 (0–0.9) 0.7 (0–2.6) 2.5 (0.4–8.1) 4.4 (0–12.4) 0.03 0.19
Ranges are minimum and maximum values.
a Proportion of all CCR7 cells that are naïve. b, c, d Of the CCR7 cells that are memory, proportion that are either central memory (b), effector 
memory (c) or stable memory (d) (percentages in b, c and d sum to 100).
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We show Malawians have proportionately fewer central
memory (CD45RA-CCR7+) T cells and proportionately
more CD4+ and CD8+ stable memory (CD45RA+CCR7-) T
cells than UK subjects. This is consistent with our finding
of more CD28- T cells in Malawians. Gupta et al [33]
showed in aged human subjects that almost all CD8+ sta-
ble memory T cells and a large proportion of CD8+ effec-
tor memory T cells are CD28-, whereas CD8+ naïve
(CD45RA+CCR7+) and CD8+ central memory (CD45RA-
CCR7+) T cells are CD28+. T cell recirculation and cell traf-
ficking patterns could be affected by the presence of the
large numbers of CD28- T cells. Since CD28 ligation
enhances the binding affinity of T cells to endothelial cells
[34], the trafficking of T cells lacking CD28 between
blood and tissues may be altered. Memory CD8 T cells in
humans that are categorised according to the chemokine
receptors (CCR7) and reacquisition of the CD45RA (naïve
T cell) marker do show different homing characteristics
[35].
All of the Malawian adolescents were seropositive for
CMV compared to only 36% of the UK adolescents. We
find that CMV seropositivity in teenagers is associated
with a reduction in the percentages of naïve T cells and an
increase in the proportion of CD28- memory (CD28-
CD45RO+) CD4+ and CD8+ T cells, similar to those seen
in elderly CMV seropositive individuals [10] and consist-
ent with other studies of the phenotype of CD8+ T cells
and CMV infection [27,36]. Furthermore, the percentages
of naïve and memory T cells in CMV seropositive UK indi-
viduals are intermediate between those of CMV seronega-
tive UK adolescents and Malawian adolescents. This is
similar to differences seen between young and elderly
CMV seropositive individuals, where CMV-specific CD4+
T cells were found to be more differentiated in an elderly
cohort compared to a young group [12]. The accumula-
tion of effector memory (CD45RA-CCR7-) and stable
memory (CD45RA+CCR7-) T cells that we see resembles
the pattern which emerges when CD8+ memory cells are
analysed by tetramer (A2-CMV) staining [37].
The differences observed in T cell phenotypes between
Malawian and UK adolescents could be due to a number
of factors including; genetics, nutritional status and/or
antigenic exposure due to the increased frequency of
infectious diseases such as malaria, helminths and CMV.
CMV seropositivity has been associated with large oligo-
clonal expansions of highly differentiated CD28- and
CD57+ T cells and the presence of these differentiated T
cells implies that the repertoire of both memory and naïve
T cells available to respond to other antigens may be
decreased [11,38]. In a study of adults (aged 19–55 years
old), in seropositive individuals the percentage of human
CMV specific T cells within the peripheral memory com-
partment was in the region of 10% for both CD4+ and
CD8+ T cells while in seronegative individuals human
CMV-specific T cells were very rare [39] suggesting human
CMV is responsible for a reduction in the diversity of the
T cell repertoire even in adulthood, prior to advanced age.
In both young and elderly CMV seropositive donors,
CMV-specific CD4+ T cells were significantly more
expanded and differentiated along the path to reduced
replicative capacity (with loss of expression of CD27 and
CD28, and shorter telomeres) than those specific for other
antigens as defined by surface phenotype [12]. Moreover,
in CMV-seropositive subjects, CD4+ T cells of different
specificities were more differentiated than the same cells
in CMV-seronegative individuals, suggesting that CMV
infection had a non-specific effect on the rate of differen-
tiation of other antigen-specific CD4+ T cells [12]. Taken
together, our results suggest that T cells from Malawian
adolescents are more highly differentiated and further
down the path to reduced immune function than T cells
from age-matched UK adolescents. Further studies are
now needed to determine if the immune function of these
more highly differentiated cells is reduced.
The reduction in naïve T cells and increase in CD28- mem-
ory T cells that we observe in Malawian adolescents is also
similar to changes observed and associated with the
highly differentiated phenotype seen in the elderly [8].
This highly differentiated phenotype observed in the
CD8+ subset has been associated with CD57 expression in
the CD45RA+ population; some of these cells have also
been shown to lack expression of CD28 [40]. Such CD28-
cells have been shown to have aberrant immune func-
tions. They have a reduced ability to proliferate [25,41]
and therefore cannot undergo further clonal expansions
in response to antigenic stimulation. Although we did not
evaluate CD57 expression in this study, if the increase in
CD28- T cells in Malawians was associated with increased
CD57 expression, reduced functional capacity and poor
proliferation in response to antigen, this might lead to
ineffective control of infections.
Finally we found greater differences between Malawi and
UK individuals in CD8+ compared to CD4+ CD28-
CD45RO+ and CCR7 memory T cells. This may be related
to differences in function between CD4+ and CD8+ T cells,
where cytotoxic (CD8+) T cells have more varied functions
and a more diverse differentiation pattern than CD4+ T
cells. We are currently exploring the effector function of
memory CD4+ and CD8+ T cell subsets in Malawi and UK
individuals of a similar age using intracellular cytokine
staining for IFNγ and perforin in conjunction with stain-
ing for CCR7 and activation markers. Preliminary data
suggest less CD8+ activation and more cell death in
Malawian compared to UK T cells (P.G-S. and A.B-S.
unpublished data).
BMC Infectious Diseases 2008, 8:139 http://www.biomedcentral.com/1471-2334/8/139
Page 9 of 10
(page number not for citation purposes)
Our finding of reduced naive cells and increased antigen-
experienced T cells and CMV seroprevalence in young
Malawians compared to age-matched UK individuals sug-
gests that immune responses in rural African settings may
be induced and maintained in a very different way than in
developed countries. This may impact on both protection
against infectious diseases and the ability of vaccines to
induce long-lived immunity.
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